GLP-1 Medications Can Work. Here's What Nobody's Telling You About the Risks.
There's a conversation happening right now in every gym, every doctor's office, and every group chat where someone is trying to lose weight.
Ozempic. Wegovy. Mounjaro. GLP-1 receptor agonists have gone from a niche diabetes medication to the most talked-about weight loss tool in a generation. Celebrities are on them. Your coworker is on them. Your doctor may have already mentioned them.
And they work. That part is true. The clinical data on GLP-1 medications for weight loss is real and it's meaningful. We're not here to dismiss that.
But there's a parallel conversation that isn't happening nearly enough. It's the conversation about what these medications do to your body beyond suppressing your appetite, and what happens to people who use them without the right protocol around them.
That conversation is what this post is about.
The Traveling Trainer works with clients across Greater Boston, Westford, Chelmsford, Andover, and into southern New Hampshire, and we've seen this pattern enough to take it seriously. People losing significant weight on GLP-1 medications and then finding themselves weaker, more fatigued, and in some cases worse off metabolically than before they started. Not because the medication failed. Because nobody told them what the medication requires of them in return.
What GLP-1 Medications Actually Do
GLP-1 (glucagon-like peptide-1) receptor agonists work by mimicking a hormone your gut naturally produces after eating. They slow gastric emptying, increase insulin secretion in response to glucose, suppress glucagon, and most importantly for weight loss purposes, they signal satiety to the brain. You feel full faster and stay full longer. Appetite, for many people, drops dramatically.
The result is a significant reduction in caloric intake. Without trying. Without willpower. Without the constant negotiation between wanting food and resisting it that makes traditional dieting so exhausting.
For people who have struggled with appetite regulation their entire lives, this is genuinely meaningful. The playing field shifts.
But here's where the problem begins.
The Muscle Mass Problem Nobody's Talking About
When you lose weight, you don't lose only fat. You lose a combination of fat, water, and lean tissue, including muscle mass. The ratio of fat to lean mass lost depends largely on two things: how much protein you consume, and whether you're performing resistance training.
In a standard caloric deficit without resistance training, somewhere between 20-30% of the weight lost tends to come from lean mass rather than fat. That number is not fixed. It's heavily influenced by training and protein intake.
With GLP-1 medications, the caloric restriction is often more severe than traditional dieting because appetite suppression is powerful. People eating 1,000-1,400 calories per day is not unusual. And at that level of restriction, without deliberate resistance training and prioritized protein intake, lean mass loss accelerates significantly.
A 2024 analysis published in the Journal of the American Medical Association examined body composition changes in participants on semaglutide. Lean mass loss represented a substantial portion of total weight lost, particularly in participants who were not engaged in structured exercise programs.
What does losing significant lean mass actually mean for you?
Your resting metabolic rate drops. Lean tissue is metabolically active. Less of it means you burn fewer calories at rest, permanently, until that muscle is rebuilt. Your strength decreases. Your functional capacity decreases. And the weight loss, however impressive on the scale, is not the composition change you actually wanted.
People on GLP-1 medications who are losing 20, 30, 40 pounds need to understand: if you're not in the gym doing resistance training, a meaningful portion of what you're losing is muscle you worked years to build, or muscle you needed for your long-term health.
Bone Density: The Slower-Moving Risk
This one gets less attention because the consequences take longer to appear.
Weight loss itself, regardless of the mechanism, is associated with bone density reduction. This is well-documented. The mechanical loading that bones experience from carrying body weight provides an osteogenic stimulus. When body weight drops, so does that stimulus.
In older adults, this is not a minor concern. Osteoporosis and fragility fractures are among the most serious health consequences of aging, and the bone density you have at 50 and 60 is largely determined by the training and nutrition decisions you made in the preceding decades.
Resistance training is one of the most effective interventions for maintaining and building bone density. It places direct mechanical load on bone through muscular tension and impact, stimulating remodeling and density preservation. If you're losing significant weight on a GLP-1 and not doing resistance training, you are losing both muscle and bone protection simultaneously.
For women approaching or past menopause, where estrogen-related bone density decline is already occurring, this compounding effect is particularly worth taking seriously.
The Rebound Risk: What Happens When You Stop
The data on long-term outcomes for GLP-1 medications is still accumulating, but what's available is instructive.
In the STEP 1 trial extension, participants who stopped semaglutide regained approximately two-thirds of their lost weight within one year. This is not a surprise if you understand the mechanism. GLP-1 medications address appetite regulation pharmacologically. They don't change the underlying metabolic environment. They don't build the muscle that elevates resting metabolism. They don't establish the behavioral infrastructure around eating and exercise that produces lasting results.
When the medication stops, appetite returns. If the person stopping the medication has also lost significant lean mass during their time on it, their resting metabolic rate is now lower than when they started. They are, in the most literal sense, worse positioned to maintain their weight than they were before the medication began.
This is the outcome nobody signs up for when they start a GLP-1. And it's the outcome that's most preventable.
The answer is not to stay on the medication indefinitely. The answer is to use the window of appetite suppression to build the habits, the muscle mass, and the metabolic foundation that makes the weight loss sustainable beyond the medication.
The Non-Negotiables If You're on a GLP-1
If you are currently using or considering a GLP-1 medication, these are not suggestions. They are the minimum requirements for using the medication in a way that actually serves your long-term health.
Resistance training, at minimum three times per week. Compound movements. Progressive overload. Enough volume to provide a genuine stimulus for muscle retention and development. This is the single most important thing you can do alongside a GLP-1 medication and the thing most people are not doing.
Protein intake of at minimum 1.6 grams per kilogram of body weight per day, targeting the higher end. GLP-1 medications suppress appetite non-selectively. People on these medications often stop eating protein because they're simply not hungry. This is exactly backward. Protein must be prioritized at every meal. If your appetite is suppressed to the point that you can only eat a small amount, that small amount should be protein first.
Hydration. Nausea is among the most common side effects of GLP-1 medications, and reduced food intake means reduced water from food sources. Deliberate hydration maintenance is not optional.
Sleep. Covered in the previous post in this series, but the hormonal environment created by quality sleep is particularly important when you're undergoing significant body composition change. HGH secretion, cortisol regulation, and insulin sensitivity all interact with the metabolic changes GLP-1 medications produce.
Monitoring what you're actually losing. Scale weight is an incomplete metric. If you're on a GLP-1 and not getting regular body composition assessments, you have no idea whether you're losing fat, muscle, or both. A qualified coach who understands body composition can help you interpret what's actually happening and adjust your protocol accordingly.
Why a Qualified Trainer Is More Important on GLP-1, Not Less
There's a tendency for people on GLP-1 medications to feel like the medication is doing the work, so the other inputs matter less. This is precisely wrong.
The medication creates the caloric deficit. That's its job. Your job, the part that determines whether the outcome is sustainable and health-promoting or muscle-depleting and temporary, is everything else. The training. The protein. The sleep. The progressive development of a lifestyle that supports the body you're building.
The medication can produce the weight loss. The training determines what that weight loss is actually made of.
Frequently Asked Questions
Do I need to exercise while taking Ozempic or Wegovy?
Yes, and resistance training is more critical here than when dieting conventionally. Without it, a significant portion of weight lost on GLP-1 medications comes from muscle mass, which reduces your resting metabolic rate and long-term health outcomes. The medication creates the deficit. Resistance training determines what you lose.
How much protein should I eat on a GLP-1 medication?
A minimum of 1.6 grams per kilogram of body weight, targeting 1.8-2.2 grams if possible. Given the appetite suppression from GLP-1 medications, hitting this target requires deliberate meal planning and prioritizing protein before any other food at every sitting.
What exercises are best while on GLP-1 medications?
Compound resistance training movements: squats, deadlifts, rows, pressing movements, hip hinges. These recruit the most muscle mass per movement and provide the strongest signal for lean mass retention during the accelerated weight loss that GLP-1 medications produce. Along with that this will help retain bone density that is inherently lost when on these medications.
Can I lose muscle on Ozempic even if I'm losing weight?
Yes. Weight loss from any source includes some lean mass loss. GLP-1 medications often produce more rapid and aggressive weight loss than traditional dieting, which increases the lean mass loss risk. Without resistance training and adequate protein intake, this risk is substantially elevated.
What happens when you stop taking a GLP-1 medication?
Clinical trial data shows that most people regain a significant portion of lost weight after discontinuing GLP-1 medications without lifestyle changes in place. If lean mass was also lost during the medication period, the resting metabolic rate is lower than baseline, making weight regain even more likely. Building muscle and metabolic infrastructure during the medication period is the best available protection against this outcome.
